HGBL vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 21, 2026

HGBL

53.6
AI Score
VS
HGBL Wins

HIVE

47.6
AI Score

Investment Advisor Scores

HGBL

54score
Recommendation
HOLD

HIVE

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HGBL HIVE Winner
Forward P/E 18.018 62.8931 HGBL
PEG Ratio 3.6027 0 Tie
Revenue Growth -5.5% 130.5% HIVE
Earnings Growth -33.3% -99.9% HGBL
Tradestie Score 53.6/100 47.6/100 HGBL
Profit Margin 6.5% -49.9% HGBL
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HGBL 1M: -15.6% · 3M: -22.0% HIVE 1M: -12.9% · 3M: +13.3%

Current Technical Phase

HGBL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.1%), weak momentum, RSI 23

RSI (14): 22.9 · Price: $1.03

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.9 · Price: $2.95

Fundamentals Snapshot

Metric HGBL HIVE
Market Cap
Forward P/E 6.4 -5.7
Trailing P/E 12.9
Revenue (TTM)
Revenue Growth -0.1% 1.3%
Gross Margin 0.6% 0.4%
Operating Margin 0.0% -0.8%
EPS 0.09 -0.66
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HGBL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.